Network / Interactive Map / Entity profile
WntResearch AB
Investor
WntResearch AB
Description
WntResearch is developing a completely new type of cancer drug that inhibits the ability of tumour cells to spread in the body and form metastases. The company's research is focused on studying the endogenous protein WNT5A, which in scientific studies has shown to affect tumour cells' ability to move and spread in the body.
WntResearch AB
Address
Björklundabacken 10, c/o The House, 43657 Hovås
Hovås, SWEDEN
Hovås, SWEDEN
Contact
info@wntresearch.com
Description
WntResearch is developing a completely new type of cancer drug that inhibits the ability of tumour cells to spread in the body and form metastases. The company's research is focused on studying the endogenous protein WNT5A, which in scientific studies has shown to affect tumour cells' ability to move and spread in the body.
Matchmaking
Connect with WntResearch AB
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen

Identification of biotherapies
- Target identification
- Target validation
- Screening

Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies

Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production

Production
- Upstream processes
- Downstream processes
- Quality control

Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways
TRL
Not yet on COBIOE directory?
Want to access to more data?
Want to contact this entity?